TROP 2 ADCs and ADCs in SCLC
Expanding the Applicability Beyond HER2m and EGFRm: TROP-2–Targeted ADCs in NSCLC and ADCs in Patients with SCLC

Released: September 16, 2024

Expiration: September 15, 2025

David Planchard
David Planchard, MD, PhD

Activity

Progress
1
Course Completed